The co-stimulatory molecule CD40 ligand expressed from a recombinant adenoviral vector in autologous chronic lymphocytic leukemia cells has been tested in a recent clinical trial with encouraging results. The gene discussed is CD40LG; the disease is B-cell chronic lymphocytic leukemia.